HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsunori Yanagihara Selected Research

Erythromycin (Erycette)

10/2021Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation.
9/2008A case of Legionella pneumophila pneumonia followed by invasive aspergillosis.
1/2008Severe Legionnaires' disease successfully treated using a combination of fluoroquinolone, erythromycin, corticosteroid, and sivelestat.
1/2007Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection.
6/2004Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
4/2003[Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsunori Yanagihara Research Topics

Disease

81Infections
11/2022 - 01/2002
60Pneumonia (Pneumonitis)
11/2022 - 05/2002
15Communicable Diseases (Infectious Diseases)
01/2021 - 06/2004
13Respiratory Tract Infections (Respiratory Tract Infection)
09/2018 - 06/2004
11Human Influenza (Influenza)
02/2021 - 01/2008
10Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2022 - 10/2007
9Neoplasms (Cancer)
02/2022 - 03/2009
9Bacterial Pneumonia
10/2020 - 01/2007
9Fever (Fevers)
04/2017 - 08/2003
9Diffuse panbronchiolitis
01/2012 - 05/2002
8Pneumococcal Pneumonia
10/2021 - 11/2004
8Cryptococcosis
04/2019 - 09/2005
7Chronic Obstructive Pulmonary Disease (COPD)
12/2020 - 11/2004
6Bacteremia
11/2022 - 11/2012
6Healthcare-Associated Pneumonia
02/2020 - 01/2008
6Abscess
09/2019 - 06/2013
6Sepsis (Septicemia)
09/2016 - 01/2010
6Cystic Fibrosis (Mucoviscidosis)
05/2011 - 01/2005
5Pulmonary Aspergillosis
04/2022 - 01/2010
5Disease Progression
06/2021 - 05/2012
5Pneumococcal Infections
12/2020 - 01/2009
5Inflammation (Inflammations)
01/2020 - 09/2008
4COVID-19
07/2022 - 01/2021
4Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021 - 10/2010
4Invasive Candidiasis
12/2020 - 01/2011
4Hemorrhage
12/2020 - 03/2007
4Clostridium Infections
12/2020 - 06/2018
4Bronchiectasis
01/2017 - 01/2005
4Pseudomonas Infections
01/2017 - 06/2003
4Ventilator-Associated Pneumonia
01/2017 - 08/2012
4Cross Infection (Nosocomial Infection)
07/2015 - 06/2008
4Carcinogenesis
12/2014 - 04/2008
4Tuberculosis (Tuberculoses)
02/2014 - 01/2002
4Coinfection
07/2013 - 01/2008
3Aspiration Pneumonia
01/2022 - 04/2013
3Lung Neoplasms (Lung Cancer)
05/2021 - 03/2008
3T-Cell Leukemia (Leukemia, T Cell)
03/2021 - 02/2012
3Respiratory Insufficiency (Respiratory Failure)
12/2020 - 03/2014
3Septic Shock (Toxic Shock Syndrome)
01/2020 - 02/2010
3Liver Diseases (Liver Disease)
04/2019 - 01/2012
3Intraabdominal Infections
01/2019 - 07/2017
3Body Weight (Weight, Body)
01/2017 - 01/2006
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2017 - 06/2009
3Neoplasm Metastasis (Metastasis)
01/2017 - 03/2009
3Cough
02/2014 - 01/2009
3Rheumatoid Arthritis
01/2014 - 02/2008
3Pleural Effusion (Pleural Effusions)
01/2014 - 01/2002

Drug/Important Bio-Agent (IBA)

51Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 01/2002
23MacrolidesIBA
10/2021 - 05/2002
15Pharmaceutical PreparationsIBA
01/2021 - 01/2007
13VancomycinFDA LinkGeneric
02/2020 - 10/2002
12AntigensIBA
07/2022 - 09/2005
12Clarithromycin (Biaxin)FDA LinkGeneric
10/2021 - 01/2002
10CytokinesIBA
04/2022 - 07/2007
10Linezolid (Zyvox)FDA Link
02/2020 - 10/2002
9Azithromycin (Zithromax)FDA LinkGeneric
05/2021 - 11/2007
8Proteins (Proteins, Gene)FDA Link
07/2022 - 09/2003
8Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2007
8Anti-Infective Agents (Microbicides)IBA
01/2021 - 01/2004
8Carbapenems (Carbapenem Antibiotics)IBA
12/2020 - 06/2008
8SteroidsIBA
12/2020 - 01/2008
8Ciprofloxacin (Cipro)FDA LinkGeneric
05/2018 - 12/2003
7DNA (Deoxyribonucleic Acid)IBA
10/2021 - 09/2008
7Micafungin (FK463)FDA Link
10/2020 - 09/2008
7QuinolonesIBA
11/2019 - 12/2003
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 02/2013
6Erythromycin (Erycette)FDA LinkGeneric
10/2021 - 04/2003
6Meropenem (Merrem)FDA LinkGeneric
12/2020 - 12/2008
6C-Reactive ProteinIBA
09/2017 - 07/2007
6MucinsIBA
04/2013 - 09/2003
5sitafloxacinIBA
11/2019 - 01/2006
5Adrenal Cortex Hormones (Corticosteroids)IBA
12/2017 - 01/2007
5FluoroquinolonesIBA
01/2017 - 01/2006
5Ampicillin (Omnipen)FDA LinkGeneric
12/2013 - 01/2006
4liposomal amphotericin BFDA Link
09/2022 - 08/2009
4Oxygen (Dioxygen)IBA
04/2021 - 01/2010
4Voriconazole (Vfend)FDA LinkGeneric
01/2020 - 09/2008
4Levofloxacin (Levaquin)FDA Link
03/2017 - 06/2004
4beta-Lactamases (beta-Lactamase)IBA
01/2017 - 01/2007
4Oseltamivir (Tamiflu)FDA Link
01/2017 - 01/2008
4Biological ProductsIBA
01/2016 - 02/2014
4sivelestatIBA
10/2010 - 03/2007
3AgarIBA
11/2022 - 11/2008
3AzolesIBA
06/2021 - 01/2011
3Rifampin (Rifampicin)FDA LinkGeneric
04/2021 - 01/2002
3EnzymesIBA
02/2021 - 01/2014
3Antifungal AgentsIBA
10/2020 - 01/2016
3EchinocandinsIBA
10/2020 - 11/2014
3TeicoplaninIBA
02/2020 - 10/2002
3Itraconazole (Sporanox)FDA LinkGeneric
01/2020 - 01/2010
3DaptomycinFDA Link
01/2019 - 06/2013
3Metronidazole (Metric)FDA LinkGeneric
11/2018 - 03/2009
3Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
05/2018 - 01/2006
3polyglucosanIBA
04/2017 - 01/2011
3arbekacinIBA
01/2017 - 04/2012
3Pancreatic Elastase (Elastase)IBA
01/2016 - 06/2003
3SulbactamFDA LinkGeneric
12/2013 - 01/2006

Therapy/Procedure

40Therapeutics
07/2021 - 04/2003
9Drug Therapy (Chemotherapy)
09/2020 - 01/2010
3Aftercare (After-Treatment)
04/2019 - 02/2010